The FDA has approved bemotrizinol as a new sunscreen active ingredient, the first such addition in 20 years. - Bemotrizinol provides broad-spectrum UVA/UVB protection with low skin absorption.
- It is considered safe for adults and children 6 months and older. - The approval follows a streamlined process under the CARES Act and public comments.
- The ingredient has been used in Europe for decades. This move aims to boost innovation and consumer confidence in sunscreens.